Literature DB >> 6339413

The distribution of Klebsiella pneumoniae serotypes from different sources and their sensitivity to cephalosporins.

U Ullmann.   

Abstract

153 strains of Klebsiella pneumoniae from 16 microbiological institutes in Germany, Austria and Switzerland were typed biochemically and serologically; their sensitivities to cefoxitin, cefotaxime, ceftazidime, ceftriaxone, lamoxactam, thienamycin and gentamicin were determined. The strains could be classified into seven biotypes and 43 K-antigen types. The distribution of the K-antigen types was random, and spread over the whole spectrum of the 72 possibilities. Regional variations were not observed. 4.6% of the isolates were resistant to cefoxitin and 23% were moderately sensitive. 98% of these Klebsiella strains were sensitive to the new cephalosporins which were also effective against gentamicin-resistant isolates accounting for 12% of all isolates studied. Cefoxitin was only slightly active against such strains. The effect of a standard concentration of each agent on bacterial cultures during their growth phase was measured in the Jouan biophotometer. The beta-lactamase-stable cephalosporins had a permanent bactericidal effect on the enzyme-producing reference strain, although the latent period varied considerably in some cases. Piperacillin and cefoperazone were not bactericidal in this test.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339413     DOI: 10.1007/bf01641102

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Serological investigations in the Klebsiella group. I. New capsule types.

Authors:  I ØRSKOV
Journal:  Acta Pathol Microbiol Scand       Date:  1955

2.  A hospital epidemic caused by gentamicin-resistant Klebsiella aerogenes.

Authors:  K Curie; D C Speller; R A Simpson; M Stephens; D I Cooke
Journal:  J Hyg (Lond)       Date:  1978-02

3.  Experiences in the use of commercial antisera for the capsular typing of klebsiella species.

Authors:  M W Casewell
Journal:  J Clin Pathol       Date:  1972-08       Impact factor: 3.411

4.  [Hospital-acquired infections in a university health centre: prospective analysis of 39 802 patients (author's transl)].

Authors:  F Daschner
Journal:  Dtsch Med Wochenschr       Date:  1981-01-23       Impact factor: 0.628

5.  Seroepidemiology of clinical isolates of Klebsiella in Connecticut.

Authors:  E A Blanchette; S J Rubin
Journal:  J Clin Microbiol       Date:  1980-05       Impact factor: 5.948

6.  Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

7.  [In vitro experiments on the working of combinations of gentamicin and beta-lactam antibiotics against Pseudonomas aeruginosa (author's transl)].

Authors:  U Ullmann
Journal:  Immun Infekt       Date:  1975-04

8.  Bacteriocin (klebocin) sensitivity typing of klebsiella.

Authors:  C L Buffenmyer; R R Rycheck; R B Yee
Journal:  J Clin Microbiol       Date:  1976-09       Impact factor: 5.948

9.  Bacteriocins as tools in analysis of nosocomial Klebsiella pneumoniae infections.

Authors:  A Bauernfeind; C Petermüller; R Schneider
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

10.  Epidemiological patterns of Klebsiella colonization and infection in an intensive care ward.

Authors:  M W Casewell; I Phillips
Journal:  J Hyg (Lond)       Date:  1978-04
  10 in total
  7 in total

1.  Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development.

Authors:  S J Cryz; P M Mortimer; V Mansfield; R Germanier
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

2.  Incidence of Klebsiella species in surface waters and their expression of virulence factors.

Authors:  R Podschun; S Pietsch; C Höller; U Ullmann
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

3.  Binding to and opsonophagocytic activity of O-antigen-specific monoclonal antibodies against encapsulated and nonencapsulated Klebsiella pneumoniae serotype O1 strains.

Authors:  T K Held; N R Jendrike; T Rukavina; R Podschun; M Trautmann
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

4.  Isolation of Klebsiella terrigena from clinical specimens.

Authors:  R Podschun; U Ullmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

Review 5.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

Review 6.  Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

7.  Isolation of Klebsiella planticola from newborns in a neonatal ward.

Authors:  R Podschun; H Acktun; J Okpara; O Linderkamp; U Ullmann; M Borneff-Lipp
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.